June 2026Harness Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance Parkinson's Disease ProgrammeRead more
February 2026Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory BoardRead more
October 2025Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture InvestmentRead more